Morningstar

Dr. David Berman to Join Moderna as Chief Development Officer

CAMBRIDGE, MASSACHUSETTS / ACCESS Newswire / January 30, 2026 / Moderna, Inc. (NASDAQ:MRNA) today announced that David Berman, M.D., Ph.D. has been appointed as the Company's Chief Development Officer ...
Seeking Alpha

Dr. David Berman to Join Moderna as Chief Development Officer

CAMBRIDGE, MASSACHUSETTS / ACCESS Newswire / January 30, 2026 / Moderna, Inc. (MRNA) today announced that David Berman, M.D., Ph.D. has been appointed as the Company's Chief Development Officer, ...
USA Today

Dr. David Berman to Join Moderna as Chief Development Officer

CAMBRIDGE, MASSACHUSETTS / ACCESS Newswire / January 30, 2026 / Moderna, Inc. (NASDAQ:MRNA) today announced that David Berman, M.D., Ph.D. has been appointed as the Company’s Chief Development Officer ...
CNBC

Moderna halts development of birth defect vaccine after trial setback

Moderna said on Wednesday it would discontinue development of its experimental vaccine to prevent cytomegalovirus, a common cause of birth defects, after it failed to meet the main goal of a ...
AOL

Moderna halts development of birth defect vaccine after trial setback

(Reuters) -Moderna said on Wednesday it would discontinue development of its experimental vaccine to prevent cytomegalovirus, a common cause of birth defects, after it failed to meet the main goal of ...